4D Molecular Therapeutics Inc. (FDMT) Social Stream
4D MOLECULAR THERAPEUTICS INC (FDMT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering FDMT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 2 | $70 | $45 | $57.5 | $18.8 | 205.85% |
| 2022-01-04 | 3 | $45 | $30 | $37.5 | $18.8 | 99.47% |
| 2022-03-29 | 2 | $42 | $30 | $36 | $18.8 | 91.49% |
| 2022-04-04 | 2 | $37 | $30 | $33.5 | $18.8 | 78.19% |
| 2022-05-12 | 2 | $37 | $28 | $32.5 | $18.8 | 72.87% |
| 2022-05-27 | 2 | $28 | $15 | $21.5 | $18.8 | 14.36% |
| 2022-06-22 | 3 | $28 | $15 | $21.666 | $18.8 | 15.24% |
| 2022-08-13 | 3 | $28 | $15 | $21.666 | $18.8 | 15.24% |
| 2022-09-17 | 3 | $22 | $12 | $16.333 | $18.8 | -13.12% |
| 2022-10-27 | 3 | $22 | $10 | $15.666 | $18.8 | -16.67% |
| 2022-11-11 | 3 | $22 | $11 | $16 | $18.8 | -14.89% |
| 2022-11-14 | 4 | $45 | $11 | $23.25 | $18.8 | 23.67% |
| 2022-11-15 | 4 | $68.001 | $15 | $35 | $18.8 | 86.17% |
| 2022-11-21 | 5 | $68.001 | $15 | $35.166 | $18.8 | 87.05% |
| 2023-01-25 | 5 | $68.001 | $15 | $36 | $18.8 | 91.49% |
| 2023-02-03 | 6 | $68.001 | $15 | $38 | $18.8 | 102.13% |
| 2023-02-08 | 6 | $68.001 | $14 | $37.571 | $18.8 | 99.85% |
| 2023-03-27 | 6 | $68.001 | $14 | $37.857 | $18.8 | 101.37% |
| 2023-04-27 | 6 | $68.001 | $13 | $37.714 | $18.8 | 100.61% |
| 2023-05-05 | 6 | $68.001 | $22 | $39 | $18.8 | 107.45% |
| 2023-05-11 | 6 | $68.001 | $21 | $38.857 | $18.8 | 106.69% |
| 2023-06-06 | 6 | $68.001 | $23 | $39.143 | $18.8 | 108.21% |
| 2023-06-07 | 6 | $68.001 | $23 | $39.857 | $18.8 | 112.01% |
| 2023-06-08 | 7 | $68.001 | $23 | $40.571 | $18.8 | 115.8% |
| 2023-07-05 | 7 | $68.001 | $23 | $39.25 | $18.8 | 108.78% |
| 2023-07-11 | 7 | $68.001 | $24 | $39.5 | $18.8 | 110.11% |
| 2023-08-14 | 7 | $68.001 | $22 | $39.25 | $18.8 | 108.78% |
| 2023-10-19 | 8 | $68.001 | $24 | $39.5 | $18.8 | 110.11% |
| 2023-10-25 | 8 | $68.001 | $24 | $38.666 | $18.8 | 105.67% |
| 2023-10-30 | 8 | $68.001 | $25 | $38.777 | $18.8 | 106.26% |
| 2023-11-10 | 9 | $63 | $25 | $36.9 | $18.8 | 96.28% |
| 2023-11-13 | 9 | $63 | $25 | $36.5 | $18.8 | 94.15% |
The Trend in the Analyst Price Target
FDMT's average price target has moved up $13.89 over the prior 17 months.
FDMT reports an average of 154.32% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 6 | 68.001 | 14 | 37.571 | 20.54 | 82.92% |
| 2023-04-13 | 6 | 68.001 | 13 | 37.714 | 16.85 | 123.82% |
| 2023-06-06 | 6 | 68.001 | 23 | 39.143 | 19.22 | 103.66% |
| 2023-06-08 | 7 | 68.001 | 23 | 40.571 | 19.52 | 107.84% |
| 2023-11-10 | 9 | 63.000 | 25 | 36.900 | 11.05 | 233.94% |
FDMT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.11 | 8 | 1 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
FDMT's average broker recommendation rating improved by 0.39 over the prior 52 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FDMT as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, 4D MOLECULAR THERAPEUTICS INC's variance in analysts' estimates is lower than -3207.39% of them.
- In terms of how 4D MOLECULAR THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2282.65% of that group.
- In the context of stocks in the small market cap category, 4D MOLECULAR THERAPEUTICS INC's average analyst price target is higher than 3190.6% of them.
- FDMT has a higher upside potential (average analyst target price relative to current price) than 2024.49% of stocks in the small market cap category.
Stocks similar to 4D MOLECULAR THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CGEM, SABS, and VOR.
View All Top Stocks by Price Target
Is FDMT a Buy, Hold or Sell? See the POWR Ratings now!